Physician Assistant · Charleston, SC
NPI
1376520171
Since 2005
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
9295 Medical Plaza Dr, Suite B
Charleston, SC, 29406
Phone (843) 797-3960
Groups this clinician bills Medicare through
Medicare paid, 2024
$287K
9,511 services
Medicare patients, 2024
1,329
Average age 76
Drug cost, 2024
$1.5M
1,606 prescriptions
Company payments, 2025
$42K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael D Overcash was code 17003 (destruction skin lesion), 3,752 times for 604 patients. In total Michael D Overcash billed 9,511 services in 67 codes, and Medicare paid $287K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,752 | 604 | $3.98 | $15K |
| 99214 Office E&M - Established | Office | 1,068 | 765 | $68.78 | $73K |
| 17000 Destruction Skin Lesion | Office | 958 | 753 | $25.39 | $24K |
| 17110 Destruction Skin Lesion | Office | 760 | 620 | $55.32 | $42K |
| 99213 Office E&M - Established | Office | 758 | 641 | $48.94 | $37K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 472 | 66 | $0.71 | $334 |
| 11301 Removal or Shaving of Skin Growth | Office | 262 | 206 | $54.33 | $14K |
| 11302 Removal or Shaving of Skin Growth | Office | 158 | 127 | $68.58 | $11K |
| 17004 Destruction Skin Lesion | Office | 142 | 112 | $92.57 | $13K |
| 11310 Removal or Shaving of Skin Growth | Office | 105 | 87 | $49.22 | $5,168 |
| 11311 Removal or Shaving of Skin Growth | Office | 101 | 84 | $60.20 | $6,080 |
| 96372 Injection Administration | Office | 99 | 47 | $8.25 | $817 |
| 99212 Office E&M - Established | Office | 88 | 82 | $34.82 | $3,064 |
| 11306 Removal or Shaving of Skin Growth | Office | 86 | 69 | $61.23 | $5,266 |
| 11200 Removal or Shaving of Skin Growth | Office | 79 | 76 | $30.23 | $2,388 |
By year: 2022 $209K for 6,645 services; 2023 $217K for 6,848 services; 2024 $287K for 9,511 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87101 General Laboratory | 19 | 18 | $7.24 | $138 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael D Overcash prescribed most often to Medicare patients was Clobetasol Propionate, with 211 prescriptions and refills. In total Michael D Overcash wrote 1,606 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 211 | 223 | 108 | $9,084 |
| Minoxidil Generic | 168 | 476 | 58 | $1,625 |
| Triamcinolone Acetonide Generic | 125 | 125 | 81 | $1,063 |
| Terbinafine Hcl Generic | 98 | 166 | 44 | $443 |
| Otezla Apremilast | 86 | 86 | Under 11 | $420K |
| Fluconazole Generic | 80 | 152 | 29 | $1,088 |
| Ammonium Lactate Generic | 77 | 77 | 39 | $1,428 |
| Ketoconazole Generic | 54 | 60 | 29 | $722 |
| Mupirocin Generic | 50 | 50 | 40 | $362 |
| Tretinoin Generic | 48 | 48 | 25 | $2,772 |
| Doxycycline Hyclate Generic | 41 | 45 | 14 | $1,132 |
| Tacrolimus Generic | 33 | 35 | 25 | $4,511 |
| Clindamycin Phosphate Generic | 31 | 34 | 11 | $957 |
| Betamethasone Dipropionate Generic | 30 | 30 | 16 | $1,181 |
| Imiquimod Generic | 27 | 27 | 22 | $453 |
Brand drugs: 218 claims; generic drugs: 1,388 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael D Overcash $42K ($42K in general payments such as food, travel and fees) from 22 companies. The largest payer was Janssen Biotech, Inc. with $22K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 31 | $22K |
| Arcutis Biotherapeutics, Inc. ARQT | 18 | $9,102 |
| Incyte Corporation INCY | 22 | $4,239 |
| Kowa Pharmaceuticals America, Inc. | 3 | $2,324 |
| E.R. Squibb & Sons, L.L.C. BMY | 7 | $1,590 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $307 |
| Genzyme Corporation SNY | 10 | $278 |
| Abbvie Inc. ABBV | 12 | $254 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 14 | $241 |
| Galderma Laboratories, L.P. GALD.SW | 13 | $207 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.